SENS PubMed Publication Search
Successes and failures for drugs in late-stage development for Alzheimer’s disease.
Berk C, Sabbagh MN
Abstract:
.....This review is a comparison of novel AD therapies in the late phases of clinical testing, including recent high-profile clinical failures, and agents in development with relatively unexplored mechanisms of action, with a focus on their potential as therapeutic agents and their proposed advantages over the treatments currently in use.
